Exploration of Copper-Cysteamine Nanoparticles As a New Type of Agents for Antimicrobial Photodynamic Inactivation.

Liyi Huang,Lun Ma,Weijun Xuan,Xiumei Zhen,Han Zheng,Wei Chen,Michael R. Hamblin
DOI: https://doi.org/10.1166/jbn.2019.2829
2019-01-01
Journal of Biomedical Nanotechnology
Abstract:Copper-cysteamine (Cu-Cy) nanoparticles (NPs) are a new type of sensitizers that can be activated by UV light, X-rays, microwaves and ultrasound to produce reactive oxygen species for cancer treatment. Here, for the first time, we explored Cu-Cy NPs for bacteria inactivation by treating gram-positive bacteria (methicillin-resistant Staphylococcus aureus and Enterococcus faecalis) and gram-negative bacteria (Escherichia coli and Acinetobacter baumannii), respectively. The results show that Cu-Cy NPs are very effective in killing gram-positive bacteria but are quite limited in killing gram-negative bacteria yet. The major killing mechanism is cell damage by singlet oxygen and Cu-Cy NPs are potential agents for bacteria inactivation.
What problem does this paper attempt to address?